Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

NCT01213030 is registered in ClinicalTrials.gov with Siemens Molecular Imaging as lead sponsor.

NCT NCT01213030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01213030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of the New Hypoxia Imaging Agent HX4
Lead sponsor
Siemens Molecular Imaging
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2009
Completion date
May 31, 2010
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, liver cancer, lung cancer